Inventor · disambiguated record
Todd M. Heidelbaugh
Also filed as: HEIDELBAUGH TODD · HEIDELBAUGH TODD M
59 granted patents·21 pending applications·456 citations·filing 2001–2021
98Inventor score
Top patents by PatentIndex Score
80 records- 0197US7141597B2Nonsedating α-2 agonistsALLERGAN INC·Filed 2004·Granted Nov 28, 2006·76 cites·13 claims
- 0297US7091232B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2003·Granted Aug 15, 2006·112 cites·3 claims
- 0394US6841684B2Imidiazoles having reduced side effectsALLERGAN INC·Filed 2001·Granted Jan 11, 2005·72 cites·18 claims
- 0492US7323477B27-((1H-imidazol-4-yl)methyl)-5,6,7,8-tetrahydroquinolineALLERGAN INC·Filed 2006·Granted Jan 29, 2008·22 cites·11 claims
- 0592US7323485B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2006·Granted Jan 29, 2008·7 cites·5 claims
- 0692US7276522B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2004·Granted Oct 2, 2007·44 cites·3 claims
- 0790US7943641B27-((1H-imidazol-4-yl)methyl)-5,6,7,8-tetrahydroquinolineALLERGAN INC·Filed 2008·Granted May 17, 2011·7 cites·2 claims
- 0890US7902247B2Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptorsALLERGAN INC·Filed 2008·Granted Mar 8, 2011·12 cites·15 claims
- 0990US7345077B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2005·Granted Mar 18, 2008·12 cites·20 claims
- 1089US7399868B24-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonistsALLERGAN INC·Filed 2005·Granted Jul 15, 2008·11 cites·7 claims
- 1188US7419994B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2006·Granted Sep 2, 2008·8 cites·16 claims
- 1287US8063231B2Methods of treating alpha adrenergic mediated conditionsFANG WENKUI K·Filed 2009·Granted Nov 22, 2011·4 cites·1 claims
- 1386US7312238B2Nonsedating α-2 agonistsALLERGAN INC·Filed 2006·Granted Dec 25, 2007·5 cites·3 claims
- 1485US7358269B22-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronapthalen-1(2H)-oneALLERGAN INC·Filed 2006·Granted Apr 15, 2008·6 cites·6 claims
- 1584US8329918B2Selective alpha 2B/2C agonistsNGUYEN PHONG X·Filed 2010·Granted Dec 11, 2012·7 cites·2 claims
- 1683US7396849B24-(Condensed cyclicmethyl)-imidazole-2-thiones acting as α2 adrenergic agonistsALLERGAN INC·Filed 2005·Granted Jul 8, 2008·5 cites·21 claims
- 1782US8735438B2Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptorsSINHA SANTOSH C·Filed 2010·Granted May 27, 2014·5 cites·5 claims
- 1882US8071636B2Methods of treating alpha adrenergic mediated conditionsFANG WENKUI K·Filed 2009·Granted Dec 6, 2011·4 cites·17 claims
- 1982US8063087B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compoundsCHOW KEN·Filed 2008·Granted Nov 22, 2011·4 cites·9 claims
- 2082US7683089B14-(Phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonistsALLERGAN INC·Filed 2005·Granted Mar 23, 2010·4 cites·2 claims
- 2181US7569584B24-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-2-thione as specific alpha2b agonist and methods of using the sameALLERGAN INC·Filed 2007·Granted Aug 4, 2009·4 cites·11 claims
- 2280US2023062049A1Methods of treating alpha adrenergic mediated conditionsALLERGAN INC·Filed 2021·Application pending·0 cites
- 2379US9849113B2Methods of treating α adrenergic mediated conditionsALLERGAN INC·Filed 2017·Granted Dec 26, 2017·1 cites·5 claims
- 2478US8227499B2Substituted-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptorsSINHA SANTOSH C·Filed 2009·Granted Jul 24, 2012·2 cites·22 claims
- 2577US9572792B2Coumarin compounds as receptor modulators with therapeutic utilityALLERGAN INC·Filed 2015·Granted Feb 21, 2017·2 cites·5 claims
- 2677US8653270B2Compounds as receptor modulators with therapeutic utilityHEIDELBAUGH TODD M·Filed 2011·Granted Feb 18, 2014·3 cites·17 claims
- 2777US8013169B2Naphthylmethylimidizoles as therapeutic agentsALLERGAN INC·Filed 2008·Granted Sep 6, 2011·2 cites·13 claims
- 2877US7868020B2Quinolynylmethylimidizoles as therapeutic agentsALLERGAN INC·Filed 2008·Granted Jan 11, 2011·2 cites·15 claims
- 2976US8124774B2Therapeutic ((phenyl)imidazolyl)methylquinolinyl compoundsSINHA SANTOSH C·Filed 2008·Granted Feb 28, 2012·2 cites·3 claims
- 3075US9623006B2Methods of treating α adrenergic mediated conditionsALLERGAN INC·Filed 2015·Granted Apr 18, 2017·1 cites·5 claims
- 3174US8426454B2Therapeutic compoundsSINHA SANTOSH C·Filed 2008·Granted Apr 23, 2013·1 cites·12 claims
- 3273US9034910B2Methods of treating alpha adrenergic mediated conditionsGIL DANIEL W·Filed 2011·Granted May 19, 2015·1 cites·17 claims
- 3373US7390829B2Alpha-2 adrenergic agonistsALLERGAN INC·Filed 2005·Granted Jun 24, 2008·1 cites·8 claims
- 3472US9073888B2Coumarin compounds as receptor modulators with therapeutic utilityHEIDELBAUGH TODD M·Filed 2010·Granted Jul 7, 2015·2 cites·6 claims
- 3572US8486969B2Therapeutic compoundsSINHA SANTOSH C·Filed 2008·Granted Jul 16, 2013·1 cites·11 claims
- 3671US8178571B2Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the sameHEIDELBAUGH TODD M·Filed 2010·Granted May 15, 2012·1 cites·7 claims
- 3771US2020330428A1Methods of treating alpha adrenergic mediated conditionsALLERGAN INC·Filed 2019·Application pending·0 cites
- 3870US8828973B2Compounds as receptor modulators with therapeutic utilityALLERGAN INC·Filed 2014·Granted Sep 9, 2014·1 cites·12 claims
- 3970US8653062B2Compounds as receptor modulators with therapeutic utilityNGUYEN PHONG X·Filed 2010·Granted Feb 18, 2014·1 cites·16 claims
- 4069US8741875B2Compounds as receptor modulators with therapeutic utilityALLERGAN INC·Filed 2013·Granted Jun 3, 2014·1 cites·15 claims
- 4167US7960423B2Imidazole-2-thionesALLERGAN INC·Filed 2007·Granted Jun 14, 2011·0 cites·16 claims
- 4267US2018344692A1Methods of treating alpha adrenergic mediated conditionsALLERGAN INC·Filed 2018·Application pending·0 cites
- 4366US8063086B2Imidazole-2-thionesCHOW KEN·Filed 2007·Granted Nov 22, 2011·0 cites·3 claims
- 4465US2018071260A1Methods of treating alpha adrenergic mediated conditionsALLERGAN INC·Filed 2017·Application pending·0 cites
- 4564US8071635B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazole-2-ones and related compoundsCHOW KEN·Filed 2008·Granted Dec 6, 2011·0 cites·9 claims
- 4664US2008176918A1Nonsedating Alpha-2 AgonistsALLERGAN INC·Filed 2007·Application pending·0 cites
- 4763US8735399B2Selective subtype alpha 2 adrenergic agents and methods for use thereofHEIDELBAUGH TODD M·Filed 2009·Granted May 27, 2014·0 cites·11 claims
- 4863US7569595B22-((2-thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronaphthalen-1(2H)-oneALLERGAN INC·Filed 2008·Granted Aug 4, 2009·0 cites·5 claims
- 4962US8383646B2Therapeutic ((bicylicheteroaryl)imidazolyl) methylheteroaryl compoundsALLERGAN INC·Filed 2008·Granted Feb 26, 2013·0 cites·16 claims
- 5059US8703745B1Compounds as receptor modulators with therapeutic utilityALLERGAN INC·Filed 2013·Granted Apr 22, 2014·0 cites·2 claims
Showing the top 50 of 80 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Todd M. Heidelbaugh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →